Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Senate pace slows on user fee bill

This article was originally published in Clinica

Executive Summary

Sometimes the only train running is the slow one. The US Senate began debate April 30 on a bill designed primarily to reauthorise laws that request prescription drug and medical device companies to pay the Food and Drug Administration (FDA) user fees in exchange for speedier product reviews. However, since the bill is likely to represent the only chance that members of Congress will get to address a whole host of other regulatory issues governed by the Food, Drug and Cosmetic Act, many members want to make their mark on issues that are only tangentially related.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048269

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel